Human Tissue Samples for Biomarker and Therapeutic Breakthroughs

Discovery Life Sciences offers FFPE blocks, curls, slides, flash frozen tissues, dissociated tissue cells (DTCs), and matched sets across various therapeutic areas, including oncology, autoimmune, neurology, and more.

Yes. All Discovery tissue samples undergo triple pathologist review to assess quality, confirm diagnosis, and estimate tumor content. Pathology reports and images are available upon request. Additionally, tumor content of oncology FFPE tissues are also qualified using AI.

Yes. Discovery can provide matched FFPE and frozen tissue from the same donor, including associated plasma, PBMCs, or serum. Matched sets support multi-omic studies and comparative analysis across formats.

Clinical data may include patient age, gender, diagnosis, disease stage, treatment history, and biomarker results. Discovery provides these annotations alongside tissue to support cohort selection and translational analysis. Additionally, many of our tissue samples have 2-year patient follow-up data, detailing treatment regimens, response rates, relapse or recurrence instances, survival outcomes, disease progression, co-morbidities, and additional tests conducted over the 2-year period following sample collection.

Discovery supplies oncology tissue samples from a wide range of cancer types including breast, lung, colorectal, prostate, ovarian, pancreatic, brain, and hematologic malignancies. Normal adjacent tissues are also available for most indications.

Yes. We provide tissues selected for biomarker expression such as HER2, KRAS, EGFR, PD-L1, and MSI. Contact us to request inventory from pre-characterized lots or to discuss custom collection based on your molecular criteria. Our specialty labs can also perform additional genomics, proteomics, and molecular pathology tests.